[go: up one dir, main page]

AU2001273632A1 - Polymeric, fiber matrix delivery systems for bioactive compounds - Google Patents

Polymeric, fiber matrix delivery systems for bioactive compounds

Info

Publication number
AU2001273632A1
AU2001273632A1 AU2001273632A AU7363201A AU2001273632A1 AU 2001273632 A1 AU2001273632 A1 AU 2001273632A1 AU 2001273632 A AU2001273632 A AU 2001273632A AU 7363201 A AU7363201 A AU 7363201A AU 2001273632 A1 AU2001273632 A1 AU 2001273632A1
Authority
AU
Australia
Prior art keywords
polymeric
delivery systems
fiber matrix
bioactive compounds
matrix delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001273632A
Inventor
Meriem Benjelloun
Nikhil Dhoot
Dalia El-Sherif
Baohua Han
Saravanan Kanakasabai
Frank K. Ko
Margaret A Wheatley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Drexel University
Original Assignee
Drexel University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drexel University filed Critical Drexel University
Publication of AU2001273632A1 publication Critical patent/AU2001273632A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/20—Coated or impregnated woven, knit, or nonwoven fabric which is not [a] associated with another preformed layer or fiber layer or, [b] with respect to woven and knit, characterized, respectively, by a particular or differential weave or knit, wherein the coating or impregnation is neither a foamed material nor a free metal or alloy layer
    • Y10T442/2525—Coating or impregnation functions biologically [e.g., insect repellent, antiseptic, insecticide, bactericide, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
AU2001273632A 2000-06-23 2001-06-25 Polymeric, fiber matrix delivery systems for bioactive compounds Abandoned AU2001273632A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21403400P 2000-06-23 2000-06-23
US60214034 2000-06-23
PCT/US2001/041133 WO2002000149A1 (en) 2000-06-23 2001-06-25 Polymeric, fiber matrix delivery systems for bioactive compounds

Publications (1)

Publication Number Publication Date
AU2001273632A1 true AU2001273632A1 (en) 2002-01-08

Family

ID=22797516

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001273632A Abandoned AU2001273632A1 (en) 2000-06-23 2001-06-25 Polymeric, fiber matrix delivery systems for bioactive compounds

Country Status (3)

Country Link
US (2) US20050158362A1 (en)
AU (1) AU2001273632A1 (en)
WO (1) WO2002000149A1 (en)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020081732A1 (en) 2000-10-18 2002-06-27 Bowlin Gary L. Electroprocessing in drug delivery and cell encapsulation
US7615373B2 (en) 1999-02-25 2009-11-10 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering
US6821479B1 (en) * 2001-06-12 2004-11-23 The University Of Akron Preservation of biological materials using fiber-forming techniques
US7105124B2 (en) * 2001-06-19 2006-09-12 Aaf-Mcquay, Inc. Method, apparatus and product for manufacturing nanofiber media
DE10157124A1 (en) * 2001-11-21 2003-05-28 Lohmann Therapie Syst Lts Controlled release device useful for e.g. oral or transdermal administration of pharmaceuticals comprises a microfiber including releasable active material
US20030180268A1 (en) * 2002-02-05 2003-09-25 Anthony Atala Tissue engineered construct for supplementing or replacing a damaged organ
US20040115771A1 (en) * 2002-09-27 2004-06-17 Thomas Jefferson University Recombinant collagen-like proteins
ES2713058T3 (en) * 2003-04-23 2019-05-17 Univ Akron Reactive materials sequestered
FI20045260L (en) * 2003-11-18 2005-05-19 Teknillinen Korkeakoulu Method for manufacturing a fiber structure
CN1906248B (en) * 2003-11-25 2010-06-16 旭化成化学株式会社 Matting film
US20060229735A1 (en) * 2004-10-15 2006-10-12 The Cleveland Clinic Foundation Device for tissue engineering
US20060154063A1 (en) * 2004-12-15 2006-07-13 Kazutoshi Fujihara Nanofiber construct and method of preparing thereof
US8771582B2 (en) 2005-03-04 2014-07-08 BioScurfaces, Inc. Electrospinning process for making a textile suitable for use as a medical article
US20060200232A1 (en) * 2005-03-04 2006-09-07 Phaneuf Matthew D Nanofibrous materials as drug, protein, or genetic release vehicles
US10328032B2 (en) 2005-03-04 2019-06-25 Biosurfaces, Inc. Nanofibrous materials as drug, protein, or genetic release vehicles
AU2006223063B2 (en) 2005-03-11 2011-11-17 Wake Forest University Health Sciences Tissue engineered blood vessels
JP4975013B2 (en) 2005-03-11 2012-07-11 ウエイク・フオレスト・ユニバーシテイ・ヘルス・サイエンシズ Manufacture of heart valves with engineered tissue
US20060204539A1 (en) 2005-03-11 2006-09-14 Anthony Atala Electrospun cell matrices
US20060204445A1 (en) * 2005-03-11 2006-09-14 Anthony Atala Cell scaffold matrices with image contrast agents
US8728463B2 (en) 2005-03-11 2014-05-20 Wake Forest University Health Science Production of tissue engineered digits and limbs
US7531503B2 (en) * 2005-03-11 2009-05-12 Wake Forest University Health Sciences Cell scaffold matrices with incorporated therapeutic agents
US8048446B2 (en) * 2005-05-10 2011-11-01 Drexel University Electrospun blends of natural and synthetic polymer fibers as tissue engineering scaffolds
US7704347B2 (en) * 2005-05-27 2010-04-27 Prairie Packaging, Inc. Reinforced plastic foam cup, method of and apparatus for manufacturing same
EP1888331A4 (en) * 2005-06-07 2009-07-08 Univ Akron NANOFIBER STRUCTURES FOR THE SUPPORT OF BIOLOGICAL MATERIALS
EP2664340B1 (en) 2005-06-24 2020-02-12 Duke University A direct drug delivery system based on thermally responsive biopolymers
AU2006292224B2 (en) 2005-09-19 2013-08-01 Histogenics Corporation Cell-support matrix and a method for preparation thereof
KR100751547B1 (en) 2005-11-21 2007-08-23 재단법인서울대학교산학협력재단 Support for tissue engineering and its manufacturing method, and electrospinning apparatus for manufacturing support for tissue engineering
US8334257B2 (en) 2005-12-20 2012-12-18 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
WO2007082088A2 (en) * 2006-01-12 2007-07-19 Histogenics Corporation Method for repair and reconstruction of ruptured ligaments or tendons and for treatment of ligament and tendon injuries
CA2640601C (en) * 2006-01-27 2015-12-29 The Regents Of The University Of California Biomimetic fibrous polymer scaffolds
US20080220042A1 (en) * 2006-01-27 2008-09-11 The Regents Of The University Of California Biomolecule-linked biomimetic scaffolds
US8574315B2 (en) * 2006-05-09 2013-11-05 The University Of Akron Electrospun structures and methods for forming and using same
CA2654840A1 (en) * 2006-06-09 2007-12-21 The Regents Of The University Of California Biomolecule-linked biomimetic scaffolds
DE102006061539A1 (en) * 2006-12-27 2008-07-03 Paul Hartmann Ag Layer of flat material contacting wound, includes fibrous material bonded with particles having core and casing, containing healing substance released in contact with moisture
WO2008093342A2 (en) 2007-02-01 2008-08-07 Technion Research & Development Foundation Ltd. Albumin fibers and fabrics and methods of generating and using same
US20080260794A1 (en) * 2007-02-12 2008-10-23 Lauritzen Nels J Collagen products and methods for producing collagen products
US9056151B2 (en) * 2007-02-12 2015-06-16 Warsaw Orthopedic, Inc. Methods for collagen processing and products using processed collagen
US20100018641A1 (en) * 2007-06-08 2010-01-28 Kimberly-Clark Worldwide, Inc. Methods of Applying Skin Wellness Agents to a Nonwoven Web Through Electrospinning Nanofibers
US20100070020A1 (en) 2008-06-11 2010-03-18 Nanovasc, Inc. Implantable Medical Device
US20090018643A1 (en) * 2007-06-11 2009-01-15 Nanovasc, Inc. Stents
US8293531B1 (en) 2007-08-31 2012-10-23 Clemson University Research Foundation Three-dimensional ex vivo system
US8795577B2 (en) 2007-11-30 2014-08-05 Cook Medical Technologies Llc Needle-to-needle electrospinning
US7799261B2 (en) * 2007-11-30 2010-09-21 Cook Incorporated Needle-to-needle electrospinning
EP2247320B1 (en) * 2008-01-29 2013-05-29 Zimmer Inc. Implant device for use in an implant system
US20100249924A1 (en) * 2009-03-27 2010-09-30 Allergan, Inc. Bioerodible matrix for tissue involvement
RU2589255C2 (en) 2009-08-14 2016-07-10 Фейзбайо Фармасьютикалз, Инк. Modified vasoactive intestinal peptides
US8637109B2 (en) * 2009-12-03 2014-01-28 Cook Medical Technologies Llc Manufacturing methods for covering endoluminal prostheses
US8460691B2 (en) 2010-04-23 2013-06-11 Warsaw Orthopedic, Inc. Fenestrated wound repair scaffold
US8790699B2 (en) 2010-04-23 2014-07-29 Warsaw Orthpedic, Inc. Foam-formed collagen strand
BR112012032169B1 (en) 2010-06-17 2020-04-14 Univ Washington system to produce a structure that includes radially aligned fibers and fiber structure to repair an empty space in biological tissue
US9205089B2 (en) 2011-04-29 2015-12-08 Massachusetts Institute Of Technology Layer processing for pharmaceuticals
US9561262B2 (en) 2011-06-06 2017-02-07 Phasebio Pharmaceuticals, Inc. Use of modified vasoactive intestinal peptides in the treatment of hypertension
US9175427B2 (en) 2011-11-14 2015-11-03 Cook Medical Technologies Llc Electrospun patterned stent graft covering
DK3108881T3 (en) * 2012-03-30 2018-11-12 Univ Catalunya Politecnica NON-WOVEN MEMBRANE AS A PHARMACEUTICAL DELIVERY SYSTEM
WO2013165604A1 (en) * 2012-05-02 2013-11-07 Massachusetts Institute Of Technology Electroprocessing of active pharmaceutical ingredients
US20140017263A1 (en) 2012-06-28 2014-01-16 Clemson University Delivery Agents for Targeted Treatment of Elastin Degradation
WO2014046669A1 (en) 2012-09-21 2014-03-27 Washington University Biomedical patches with spatially arranged fibers
US10154918B2 (en) 2012-12-28 2018-12-18 Cook Medical Technologies Llc Endoluminal prosthesis with fiber matrix
WO2014190038A2 (en) 2013-05-22 2014-11-27 The Penn State Research Foundation Wound dressings and applications thereof
CN103599090A (en) * 2013-07-30 2014-02-26 江南大学 Multi-layer drug sustain-release nano fiber membrane and preparation method thereof
US9795573B2 (en) 2013-09-24 2017-10-24 Clemson University Multi-step connective tissue stabilization method and stabilized tissue formed thereby
US10092679B2 (en) 2013-10-18 2018-10-09 Wake Forest University Health Sciences Laminous vascular constructs combining cell sheet engineering and electrospinning technologies
WO2015179461A1 (en) 2014-05-20 2015-11-26 Massachusetts Institute Of Technology Plasticity induced bonding
EP3177329B1 (en) * 2014-08-04 2019-12-18 Hospital Sant Joan de Deu System for the immediate release of active agents
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
KR101810080B1 (en) * 2015-06-01 2017-12-19 주식회사 아모라이프사이언스 Membrane for dental
CN105908363B (en) * 2016-05-12 2018-07-06 华南农业大学 A kind of electrostatic spraying laminated film and preparation method and application
US10632228B2 (en) 2016-05-12 2020-04-28 Acera Surgical, Inc. Tissue substitute materials and methods for tissue repair
DK3533458T3 (en) * 2018-03-02 2023-06-26 Upm Kymmene Corp A medical product comprising a bioactive molecule immobilized to nanofibrillar cellulose, and a method for preparing thereof
PL3829549T3 (en) * 2018-08-03 2023-03-20 Cebiotex, S.L. Beaded nonwoven membrane as a drug delivery system
IL285026B2 (en) 2019-01-22 2025-07-01 Univ Clemson Res Foundation Anti-elastin antibodies and methods of use
CN114053249B (en) * 2020-08-10 2023-06-02 山东百多安医疗器械股份有限公司 Degradable medicine carrying film capable of treating systemic osteoporosis and preparation process thereof
CA3227437A1 (en) 2021-07-29 2023-02-02 Acera Surgical, Inc. Particle-form hybrid-scale fiber matrix
EP4376908A4 (en) 2021-07-29 2025-05-28 Acera Surgical, Inc. Combined macro- and microporous fiber matrix in hybrid size
WO2023039381A1 (en) 2021-09-07 2023-03-16 Acera Surgical, Inc. Materials and methods for nerve repair and regeneration

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR707191A (en) 1929-12-07 1931-07-03 Ver Fur Chemische Ind Ag Process for making artificial threads
US3991766A (en) 1973-05-31 1976-11-16 American Cyanamid Company Controlled release of medicaments using polymers from glycolic acid
US4818542A (en) 1983-11-14 1989-04-04 The University Of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
US4655777A (en) * 1983-12-19 1987-04-07 Southern Research Institute Method of producing biodegradable prosthesis and products therefrom
US5804178A (en) * 1986-11-20 1998-09-08 Massachusetts Institute Of Technology Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue
US5356630A (en) * 1989-02-22 1994-10-18 Massachusetts Institute Of Technology Delivery system for controlled release of bioactive factors
US5128170A (en) 1989-05-11 1992-07-07 Kanegafunchi Kagaku Kogyo Kabushiki Kaisha Method for manufacturing medical device having a highly biocompatible surface
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5769830A (en) 1991-06-28 1998-06-23 Cook Incorporated Soft tip guiding catheter
WO1995005083A1 (en) 1993-08-13 1995-02-23 Smith & Nephew Richards Inc Microporous polymeric foams and microtextured surfaces
AU1075699A (en) * 1997-10-10 1999-05-03 Allegheny Health, Education And Research Foundation Hybrid nanofibril matrices for use as tissue engineering devices
EP1123067A2 (en) * 1998-10-20 2001-08-16 TEI Biosciences, Inc. Cardiovascular components for transplantation and methods of making thereof
US6753454B1 (en) * 1999-10-08 2004-06-22 The University Of Akron Electrospun fibers and an apparatus therefor

Also Published As

Publication number Publication date
US20030021821A1 (en) 2003-01-30
US20050158362A1 (en) 2005-07-21
WO2002000149A1 (en) 2002-01-03
US6753311B2 (en) 2004-06-22

Similar Documents

Publication Publication Date Title
AU2001273632A1 (en) Polymeric, fiber matrix delivery systems for bioactive compounds
AU2001288388A1 (en) Substance delivery system
AU2001241662A1 (en) Pressure controlled ink delivery system
AU2003236947A1 (en) Modified release, multiple unit drug delivery systems
AU2001273178A1 (en) Stent delivery system
ZA200107527B (en) Delivery system for dispensing volatiles.
AU2001249239A1 (en) Shared groups rostering system
AU2002244133A1 (en) Delivery systems for mycotechnologies, mycofiltration and mycoremediation
AU2001285161A1 (en) Delivery point validation system
AU2002330886A1 (en) Novel targeted delivery system for bioactive agents
AU2002301348A1 (en) Delivery system for cyclopropenes
AU2001283359A1 (en) Drug release (delivery system)
AUPR602401A0 (en) Sustained release delivery system
AU3570099A (en) Anti-microbial agent delivery system
ZA200001010B (en) Microdisperse drug delivery systems.
AU2001281171A1 (en) Medication dispensing system
AU2001268879A1 (en) Injection system for gene delivery
AU2003288608A1 (en) Controlled release, multiple unit drug delivery systems
AU2002231151A1 (en) Steerable delivery system
AU2001275992A1 (en) Date specific package delivery system
AU2001260244A1 (en) Product delivery system
AU2002354927A1 (en) Vapor delivery system
AU1738601A (en) Swellable delivery system
AU2001288392A1 (en) Delivery system for heparin-binding growth factors
AU6620600A (en) Layered block fluid delivery system